The regenerative medicine industry has a communication problem, and it isn’t a scientific one. The field now broadly accepts that mesenchymal stem/stromal cells (MSCs) exert their effects largely through paracrine signaling rather than engraftment and differentiation, a reframing captured in Arnold Caplan’s proposal to rename them “medicinal signaling cells.” What hasn’t matured is the public’s understanding of any of it. [Read more…]
Disrupting the Cell Therapy Market: Nucleus Biologics Brings Transparency, Customization & Control
In recent years, the cell culture company Nucleus Biologics has been at the forefront of market disruption. In this interview with David Sheehan (CEO), we explore how the company has been growing its team, expanding its production capabilities, launching new products, and impressively, rolling out the world’s first online portal for instantaneous custom cGMP cell culture media configuration.
The pace never slows when your mission is to enable lifesaving science! [Read more…]
How Stem Cell Research Is Shaping the Future of Tissue Regeneration in 2026
Tissue regeneration has long been a promising frontier in biomedical science. Conventional medical treatments often focus on managing symptoms or slowing disease progression. However, regenerative medicine aims to repair or replace damaged tissues entirely.
Stem cells are at the center of this transformation because of their ability to self-renew. This makes them valuable for treating diseases such as cancer, diabetes, age-related disorders, and tissue damage. Their versatility supports advances in regenerative medicine, which aims to restore damaged tissues in patients with severe medical conditions.
Advances in cellular biology, biotechnology, and clinical research have steadily expanded the understanding of how stem cells behave. Scientists continue to explore how these unique cells can rebuild damaged structures, stimulate healing processes, and improve patient outcomes. [Read more…]
Role of ELISA Immunoassay Kits in Celiac Disease Antibody Detection
Celiac disease is a chronic autoimmune disorder in which the body’s immune system mistakenly attacks the small intestine. It is triggered by the consumption of gluten, a protein found in wheat, barley and rye. The immune reaction damages the tiny finger-like projections (villi) lining the small intestine. As a result, it reduces the body’s ability to absorb nutrients from food. [Read more…]
IPS HEART’s iPSC-Derived Cell Therapy, ISX9-CPC, Secures 8th FDA Regulatory Milestone
IPS HEART Secures 8th FDA Regulatory Milestone with Rare Pediatric Drug Designation for Cardiomyopathy Associated with Muscular Dystrophies
HOUSTON–IPS HEART, Inc., a biopharmaceutical company pioneering induced pluripotent stem cell (iPSC)-derived cell replacement therapies, announced that the FDA has granted Rare Pediatric Drug Designation for ISX9-CPC, for the treatment of cardiomyopathies associated with dystrophinopathies. [Read more…]
- « Previous Page
- 1
- …
- 7
- 8
- 9
- 10
- 11
- …
- 341
- Next Page »